Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
2819
-
Total shares
-
1.3B
-
Shares change
-
+28.4M
-
Total reported value, excl. options
-
$143B
-
Value change
-
+$3.18B
-
Put/Call ratio
-
0.8
-
Number of buys
-
1088
-
Number of sells
-
-1297
-
Price
-
$110.07
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q4 2023
2,884 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q4 2023.
ABBOTT LABORATORIES - COM (ABT) has 2,819 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.3B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (156M shares), BlackRock Inc. (134M shares), Capital Research Global Investors (86.6M shares), STATE STREET CORP (74.7M shares), Capital International Investors (64.3M shares), MORGAN STANLEY (35.9M shares), GEODE CAPITAL MANAGEMENT, LLC (32.9M shares), WELLINGTON MANAGEMENT GROUP LLP (32.2M shares), NORTHERN TRUST CORP (21.6M shares), and NORGES BANK (19.2M shares).
This table shows the top 2819 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.